AUCKLAND, New Zealand, March 30, 2026 /PRNewswire/ -- Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint.

Symphony is AROA's Cellular, Acellular and Matrix-like Product (CAMP), or skin substitute,...